🔎 Trials Near Me

Home › Merkel Cell Carcinoma › Pennsylvania

Merkel Cell Carcinoma clinical trials in Pennsylvania

4 studies for Merkel Cell Carcinoma are looking for participants at sites in Pennsylvania.

Cities in Pennsylvania

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

  • UPMC Hillman Cancer Center, Pittsburgh
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 31, 2026 · NCT05896839

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

  • Research Site, Pittsburgh
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT07115043

Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma

  • UPMC Hillman Cancer Center, Pittsburgh
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Apr 17, 2026 · NCT06947928

Neoadjuvant PD-1 Blockade in Resectable Merkel Cell Carcinoma

  • Penn Medicine, Philadelphia
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 18, 2026 · NCT05496036

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.